Search

Your search keyword '"Brisson, Ryan"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Brisson, Ryan" Remove constraint Author: "Brisson, Ryan"
41 results on '"Brisson, Ryan"'

Search Results

9. Nationwide changes in radiation oncology travel and location of care before and during the COVID-19 pandemic

13. Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

15. A randomized phase II network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

16. Exploring the Feasibility and Utility of Entrustable Professional Activities in Resident Assessment and Feedback: A Pilot Survey Study.

17. Mapping Mastery: Evaluation of a Radiation Oncology Competency-Based Curriculum's Alignment with Current ACGME Milestones.

18. Dose and Volume De-Escalation for Human Papillomavirus–Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes

19. A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

20. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

22. Three-Dimensional Computed Tomography Reconstruction for Revision Parathyroidectomy

24. Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy.

25. Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy.

26. High-accuracy HPV testing versus p16 IHC using multiple clinically relevant outcomes: The University of Chicago Experience.

27. Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy.

29. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

30. Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

31. Biomarker-driven indication selection in JTX-2011 ICONIC clinical trial.

32. Correlation of constitutive PD-1 resistance in HNC with GM-CSF expression and presence of myeloid derived suppressor cells (MDSCs).

37. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

38. Response-adapted volume de-escalation (RAVD) of radiotherapy (RT) using induction chemotherapy (IC) in locally advanced head and neck squamous cell cancer (LA-HNSCC).

39. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

40. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

41. The time course of semantic and relational processing during verbal analogical reasoning.

Catalog

Books, media, physical & digital resources